cfMSC Therapy for Diabetes
NCT07495956 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-03-27
Summary
The purpose of this study is to assess the feasibility, safety and clinical efficacy of the novel clonal fetal mesenchymal stem cell (cfMSC) therapy in patients with type II diabetes mellitus.
Conditions
- Type II Diabetes Mellitus
Interventions
- BIOLOGICAL
-
cfMSC therapy for diabetes
Clonal fetal mesenchymal stem cells (cfMSCs) therapy for type II diabetes mellitus
Sponsors & Collaborators
-
Shenzhen Geno-Immune Medical Institute
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-16
- Primary Completion
- 2029-03-31
- Completion
- 2030-04-30
Countries
- China
Study Locations
More Related Trials
-
Skin Samples of Diabetic Patients and Healthy Volunteers Collection
NCT01349374 ·Status: TERMINATED ·Phase: NA
-
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
NCT02026024 ·Status: COMPLETED
-
Stressors, Coping Methods and Social Support in Diabetic Patients
NCT01159184 ·Status: COMPLETED
-
Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China
NCT01525693 ·Status: UNKNOWN
-
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
NCT00829699 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Metformin in the Diastolic Dysfunction of Metabolic Syndrome
NCT02017561 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery
NCT02166372 ·Status: RECRUITING
-
Multicenter Study of Fulminant Type 1 Diabetes in China
NCT05593081 ·Status: RECRUITING
-
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405 ·Status: COMPLETED
-
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
NCT05498974 ·Status: RECRUITING
-
Diabetic Complications and Obstructive Sleep Apnea
NCT04646941 ·Status: UNKNOWN
-
Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
NCT01055093 ·Status: RECRUITING
-
Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM
NCT06496412 ·Status: RECRUITING ·Phase: NA
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED
-
The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes
NCT01101503 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
NCT02885922 ·Status: UNKNOWN
-
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)
NCT00814190 ·Status: COMPLETED ·Phase: NA
-
Metabolic Syndrome and Prediabetes
NCT07243821 ·Status: RECRUITING
-
Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus
NCT05631561 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1
NCT00574665 ·Status: COMPLETED ·Phase: NA
-
The Imaging Genetic Study of Type 2 Diabetes and Depression
NCT03564431 ·Status: UNKNOWN
-
Telehealth-Based Chronic Disease Management for Type 2 Diabetes
NCT06719050 ·Status: NOT_YET_RECRUITING
-
Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus
NCT03102424 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes
NCT01505036 ·Status: COMPLETED ·Phase: NA